Nasal polyps are benign but potentially debilitating mucosal growths arising from chronic allergic inflammation and eosinophil-mediated tissue remodeling. Delhi NCR's severe air pollution, dust particulates, hard water minerals, and seasonal temperature extremes create a perfect antigenic storm that triggers allergic dysregulation in susceptible individuals. Chronic eosinophil recruitment and activation lead to tissue edema, mucosal hypertrophy, and eventually frank polyp formation—visible as grape-like masses on endoscopy, most commonly arising from ethmoid sinus mucosa (ethmoidal polyps) or, less frequently, from maxillary antrum (antrochoanal polyps).
Polyps cause progressive mechanical airway obstruction (graded 0–3 on nasal endoscopy), leading to chronic mouth-breathing, nocturnal hypoxemia, sleep-disordered breathing, daytime fatigue, and significant quality-of-life impairment. Equally devastating is anosmia (complete loss of smell): polyps compress olfactory nerve endings in the olfactory cleft, destroying chemoreception and robbing patients of taste, appetite, and food safety awareness (inability to detect spoilage or smoke).
Functional Endoscopic Sinus Surgery (FESS) successfully removes visible polyps, but recurrence rates are alarmingly high—30–50% within 1–5 years—because surgery addresses anatomy but not the allergic terrain that generated the polyps. Patients become trapped in a recurrence cycle: surgery → temporary relief → polyp regrowth → repeat surgery. Many patients face repeated procedures over decades.
Long-term medical management relies on high-dose intranasal corticosteroid sprays (Fluticasone, Mometasone), which suppress eosinophilic inflammation but carry risks of mucosal atrophy, systemic absorption in extended use, and paradoxical rebound congestion upon cessation. Many patients develop psychological dependence on sprays, using them indefinitely despite mucosal adaptation.
Constitutional homeopathic treatment offers a fundamentally different pathway: instead of mechanically removing polyps or chemically suppressing inflammation, we correct the underlying eosinophilic dysregulation and allergic diathesis. Individualized constitutional remedies restore Th1/Th2 lymphocyte balance, suppress eosinophil recruitment and activation, reduce mucosal edema without chemical decongestants, and gradually allow polyp tissue to shrink and resorb naturally. Simultaneously, as mucosal inflammation clears, olfactory epithelium regenerates and smell sensation recovers. For post-surgical patients, early homeopathic intervention (within 4–8 weeks of FESS) achieved documented zero recurrence over 2–3 years of follow-up.
At Gupta Computerised Homeopathic Clinic, Prof. Dr. (Mrs.) Neeraj Gupta combines 30+ years of ENT and homeopathic expertise with systematic diagnostic monitoring: serial nasal endoscopy (DNE) and CT PNS (paranasal sinuses) track polyp regression; absolute eosinophil count (AEC) and serum IgE identify allergic phenotype; olfactory threshold testing documents smell recovery. Treatment includes systematic steroid-spray weaning protocols—every 2–3 weeks, reduce spray frequency by 25–50% as mucosal inflammation resolves—avoiding rebound nasal edema. By 8–12 weeks, most patients discontinue sprays completely.
Consultations are available at Shakarpur (East Delhi, near Laxmi Nagar Metro) and Vaishali (Ghaziabad) clinics, with online consultations and home medicine delivery for outstation and international patients.